https://www.selleckchem.com/pr....oducts/purmorphamine
In the peri-endoscopic period, 103 (60%) patients were responsive to medical and/or surgical treatment and 67 (40%) patients were non-responsive. The rate of gastritis was higher in group A than in groups B and D. The incidence of duodenitis and gastric ulcer was much higher in group D. The rate of gastritis was higher in the controlled group compared to the uncontrolled group. The study showed that octreotide LAR treatment could be a risk factor in addition to known factors for the development of gastritis in patients with acrome
Like
Comment
Share
